In this week’s video, Dr. Brian Durie answers a patient’s concern about when and if to undergo an ASCT.

BOTTOM LINE:
Talk to your doctors about all the risks versus benefits of an ASCT in your case.

Have a question? Submit it to AskDrDurie@myeloma.org

IMF Chairman and Co-Founder Brian G.M. Durie, MD welcomes your questions about the latest myeloma treatments, research, controversies and quality of life issues. If you have a question you think might be of interest to the myeloma community, please send to askdrdurie@myeloma.org!

For questions of a specific personal nature, please call the IMF InfoLine coordinators at 800.452.2873 or email them at infoline@myeloma.org

Previous Post
Co-Pay Assistance Programs and Concerns
Next Post
Laura and Guy Ratzlaf

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.